Pacira BioSciences (PCRX)
(Delayed Data from NSDQ)
$26.65 USD
+0.58 (2.22%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $26.64 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Pacira BioSciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PCRX 26.65 +0.58(2.22%)
Will PCRX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PCRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PCRX
Here's What Key Metrics Tell Us About Pacira (PCRX) Q2 Earnings
Pacira (PCRX) Tops Q2 Earnings Estimates
PCRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is the Options Market Predicting a Spike in Pacira BioSciences Stock?
Pacira BioSciences Q1 Earnings Beat, Revenues Miss Estimates
Pacira (PCRX) Reports Q1 Earnings: What Key Metrics Have to Say
Other News for PCRX
Fell Below 20 Day Moving Average appears for PCRX after 1.66% move
NR7 appears for PCRX after 1.3% move
20 Day Moving Average Support appears for PCRX after 0.96% move
The technical outlook for PCRX is unchanged after it rises 0.33% on September 12
PCRX forms 20 Day Moving Average Support on September 11